DE69713989D1 - Fentanyl enthaltendes transdermal-pflaster - Google Patents
Fentanyl enthaltendes transdermal-pflasterInfo
- Publication number
- DE69713989D1 DE69713989D1 DE69713989T DE69713989T DE69713989D1 DE 69713989 D1 DE69713989 D1 DE 69713989D1 DE 69713989 T DE69713989 T DE 69713989T DE 69713989 T DE69713989 T DE 69713989T DE 69713989 D1 DE69713989 D1 DE 69713989D1
- Authority
- DE
- Germany
- Prior art keywords
- containing transdermal
- transdermal plaster
- fentanyl containing
- fentanyl
- plaster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14221096 | 1996-05-13 | ||
PCT/JP1997/001595 WO1997042952A1 (fr) | 1996-05-13 | 1997-05-13 | Preparation en ruban percutanee contenant du fentanyl |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69713989D1 true DE69713989D1 (de) | 2002-08-22 |
DE69713989T2 DE69713989T2 (de) | 2003-02-27 |
Family
ID=15309966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69713989T Expired - Lifetime DE69713989T2 (de) | 1996-05-13 | 1997-05-13 | Fentanyl enthaltendes transdermal-pflaster |
Country Status (21)
Country | Link |
---|---|
US (1) | US6139866A (de) |
EP (1) | EP0842662B1 (de) |
KR (1) | KR100486705B1 (de) |
CN (1) | CN1119997C (de) |
AR (1) | AR007090A1 (de) |
AT (1) | ATE220545T1 (de) |
AU (1) | AU734081B2 (de) |
BR (1) | BR9706591A (de) |
CA (1) | CA2226834A1 (de) |
DE (1) | DE69713989T2 (de) |
DK (1) | DK0842662T3 (de) |
ES (1) | ES2176730T3 (de) |
HK (1) | HK1009746A1 (de) |
ID (1) | ID16894A (de) |
NO (1) | NO316868B1 (de) |
PL (1) | PL188205B1 (de) |
PT (1) | PT842662E (de) |
RU (1) | RU2194496C2 (de) |
TW (1) | TW411277B (de) |
WO (1) | WO1997042952A1 (de) |
ZA (1) | ZA974073B (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775903B1 (fr) * | 1998-03-12 | 2001-06-08 | Lhd Lab Hygiene Dietetique | Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation |
US6953590B1 (en) * | 1998-10-05 | 2005-10-11 | Yutoku Pharmaceutical Ind. Co., Ltd. | Tape material for transcutaneous absorption |
EP1169025B1 (de) * | 1999-04-01 | 2005-08-24 | Alza Corporation | Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir |
US7504114B1 (en) | 1999-04-13 | 2009-03-17 | Hisamitsu Pharmaceuticals | Preparations for percutaneous absorption |
US20040142024A1 (en) * | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
BR0016402A (pt) * | 1999-12-16 | 2003-05-27 | Dermatrends Inc | Método para aumentar a permeabilidade da pele ou do tecido mucoso a agentes farmaceuticamente ou cosmeticamente ativos administrados por via tópica ou transdérmica |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US6586000B2 (en) | 1999-12-16 | 2003-07-01 | Dermatrends, Inc. | Hydroxide-releasing agents as skin permeation enhancers |
US6719997B2 (en) | 2000-06-30 | 2004-04-13 | Dermatrends, Inc. | Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers |
US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
KR100940245B1 (ko) | 2000-09-19 | 2010-02-04 | 내쇼날 스타치 앤드 케미칼 인베스트멘트 홀딩 코포레이션 | 경피 약물 전달 시스템에 유용한 비반응성 접착제 |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
AU2002235155A1 (en) * | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
PT1381352E (pt) * | 2001-03-16 | 2007-07-27 | Alza Corp | Adesivo transdérmico para administração de fenantil |
US20050208117A1 (en) * | 2001-03-16 | 2005-09-22 | Venkatraman Subramanian S | Transdermal administration of fentanyl and analogs thereof |
DE20221397U1 (de) | 2001-03-16 | 2005-10-20 | Alza Corp., Mountain View | Transdermal-Pflaster zum Verabreichen von Fentanyl |
US7247315B2 (en) * | 2001-08-17 | 2007-07-24 | Lavipharm Laboratories Inc. | Compositions and medical device for transdermal delivery of a drug and methods of making and using same |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
KR100844312B1 (ko) * | 2001-09-06 | 2008-07-07 | 노사케미컬(주) | 펜타닐 경피 투여 제제 |
US20030059450A1 (en) * | 2001-09-24 | 2003-03-27 | Maibach Howard I. | Method and topical formulation for treating skin conditions associated with aging |
US20040258741A1 (en) * | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
CA2477120C (en) * | 2002-03-06 | 2011-06-14 | Hexal Ag | Transdermal system with fentanyl |
WO2003090729A1 (en) * | 2002-04-23 | 2003-11-06 | Alza Corporation | Transdermal analgesic systems with reduced abuse potential |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
AU2003230034A1 (en) * | 2002-05-15 | 2003-12-02 | Thalas Group Incorporated | Transdermal delivery device for the administration of fentanyl |
JP4199485B2 (ja) * | 2002-06-07 | 2008-12-17 | 久光製薬株式会社 | 貼付剤 |
JP4758101B2 (ja) * | 2002-09-13 | 2011-08-24 | 久光製薬株式会社 | 貼付剤 |
TWI296531B (en) * | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
US20040086551A1 (en) * | 2002-10-30 | 2004-05-06 | Miller Kenneth J. | Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
US20040102476A1 (en) * | 2002-11-25 | 2004-05-27 | Chan Tai Wah | High concentration formulations of opioids and opioid derivatives |
JP5137286B2 (ja) * | 2003-06-10 | 2013-02-06 | 帝國製薬株式会社 | フェンタニル含有口腔粘膜貼付剤 |
RU2006100647A (ru) * | 2003-06-17 | 2006-08-10 | Хенкель Кгаа (De) | Подавление вегетативного размножения грибков эвгенолом и/или его производными |
JP4468669B2 (ja) * | 2003-09-22 | 2010-05-26 | 久光製薬株式会社 | 低刺激性貼付剤 |
AU2004286852A1 (en) | 2003-10-30 | 2005-05-19 | Alza Corporation | Transdermal analgesic systems having reduced abuse potential |
DE102004028284A1 (de) * | 2004-06-11 | 2006-01-05 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin |
JP4745747B2 (ja) | 2004-08-12 | 2011-08-10 | 日東電工株式会社 | フェンタニル含有貼付製剤 |
JP4824963B2 (ja) | 2004-08-12 | 2011-11-30 | 日東電工株式会社 | 貼付材及び貼付製剤 |
US8252319B2 (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
PL1814531T3 (pl) | 2004-10-21 | 2010-11-30 | Durect Corp | Transdermalne systemy dostarczania |
ATE413166T1 (de) | 2004-11-22 | 2008-11-15 | Hisamitsu Pharmaceutical Co | Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff |
TW200640526A (en) * | 2005-02-24 | 2006-12-01 | Alza Corp | Transdermal electrotransport drug delivery systems with reduced abuse potential |
WO2007035940A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal norelgestromin delivery system |
EP2308480B1 (de) | 2005-09-23 | 2014-08-13 | ALZA Corporation | Polyacrylatformulierung mit hoher Beladung von verstärkenden Substanzen für transdermale Anwendungen |
US20070104771A1 (en) * | 2005-09-23 | 2007-05-10 | Jay Audett | Transdermal galantamine delivery system |
DE102006019293A1 (de) * | 2006-04-21 | 2007-10-25 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Pflaster, enthaltend ein Fentanyl Analogum |
CN101442993B (zh) | 2006-08-04 | 2011-10-05 | 久光制药株式会社 | 贴剂 |
JP5275047B2 (ja) * | 2007-01-31 | 2013-08-28 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 |
BRPI0814986A2 (pt) | 2007-08-06 | 2015-02-03 | Serenity Pharmaceuticals Corp | Métodos e dispositivos para a distribuição de fármaco desmopresina. |
CN101902996B (zh) | 2007-10-15 | 2014-11-26 | 阿尔扎公司 | 芬太尼的一天更换一次透皮施用 |
AU2009210075B2 (en) | 2008-01-28 | 2013-10-24 | Teikoku Seiyaku Co., Ltd. | Fentanyl-containing patch for external use |
RU2474418C2 (ru) * | 2008-01-31 | 2013-02-10 | Хисамицу Фармасьютикал Ко., Инк. | Лейкопластырь |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
PT2296686E (pt) | 2008-05-21 | 2014-05-23 | Ferring Bv | Desmopressina orodispersível para aumentar o período inicial de sono não perturbado por noctúria |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
WO2011130455A1 (en) | 2010-04-13 | 2011-10-20 | Najib Babul | Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
EP2462927A1 (de) * | 2010-12-03 | 2012-06-13 | Hexal AG | Transdermales therapeutisches System mit Fentanyl |
KR20120107153A (ko) * | 2011-03-15 | 2012-10-02 | 아이큐어 주식회사 | 펜타닐 경피 패치제 |
CA2832490C (en) | 2011-04-13 | 2016-06-21 | Biosafe Technologies, Inc. | Compositions for internal and external insecticides, ovicides, repellents and wound healing |
US20140243765A1 (en) * | 2011-09-22 | 2014-08-28 | Samyang Biopharmaceuticals Corporation | Percutaneously absorbable preparation containing fentanyl and homologue thereof |
PT2878300T (pt) * | 2012-07-26 | 2017-08-01 | Hisamitsu Pharmaceutical Co | Penso |
CN103655523A (zh) * | 2013-12-24 | 2014-03-26 | 南京艾德凯腾生物医药有限责任公司 | 他喷他多组合物 |
US10071090B2 (en) | 2014-07-18 | 2018-09-11 | Buzzz Pharmaceuticals Limited | Oxymorphone transdermal patch |
EP3233081B1 (de) * | 2014-12-19 | 2021-09-22 | Kindeva Drug Delivery L.P. | Transdermale arzneimittelverabreichungsvorrichtung enthaltend fentanyl |
TWI687239B (zh) * | 2015-10-26 | 2020-03-11 | 日商久光製藥股份有限公司 | 貼附劑 |
FR3062572B1 (fr) * | 2017-02-03 | 2020-05-29 | B. Braun Medical | Composition adhesive et element de fixation sur la peau humaine |
US11207309B2 (en) | 2019-07-19 | 2021-12-28 | Hikma Pharmaceuticals International Limited | Ready-to-administer fentanyl formulations |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0747535B2 (ja) * | 1985-11-26 | 1995-05-24 | 日東電工株式会社 | 消炎鎮痛用貼付剤 |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
US5186939A (en) * | 1987-04-23 | 1993-02-16 | Cygnus Therapeutic Systems | Laminated composite for transdermal administration of fentanyl |
US5462744A (en) * | 1989-12-01 | 1995-10-31 | Boehringer Ingelheim Kg | Transdermal system for the administration of pharmacological compounds under pH-controlled conditions |
JP2849937B2 (ja) * | 1990-04-18 | 1999-01-27 | 日東電工株式会社 | 医療用貼付剤 |
JP3243564B2 (ja) * | 1990-08-20 | 2002-01-07 | リードケミカル株式会社 | 外用貼付剤 |
JP3541849B2 (ja) * | 1991-04-19 | 2004-07-14 | 久光製薬株式会社 | 消炎鎮痛貼付剤 |
JPH0640947A (ja) * | 1992-07-28 | 1994-02-15 | T T S Gijutsu Kenkyusho:Kk | 経皮吸収製剤用組成物および経皮吸収製剤 |
RU2136319C1 (ru) * | 1993-12-23 | 1999-09-10 | Джонсон энд Джонсон Медикал, Инк. | Биоабсорбируемое хирургическое гемостатическое средство и способ его получения (варианты) |
EP0757910B1 (de) * | 1994-04-21 | 2002-09-11 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel |
JP3908795B2 (ja) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
-
1997
- 1997-05-03 TW TW086105917A patent/TW411277B/zh not_active IP Right Cessation
- 1997-05-12 AR ARP970101969A patent/AR007090A1/es unknown
- 1997-05-12 ZA ZA9704073A patent/ZA974073B/xx unknown
- 1997-05-12 ID IDP971559A patent/ID16894A/id unknown
- 1997-05-13 AT AT97918413T patent/ATE220545T1/de not_active IP Right Cessation
- 1997-05-13 PL PL97324492A patent/PL188205B1/pl not_active IP Right Cessation
- 1997-05-13 PT PT97918413T patent/PT842662E/pt unknown
- 1997-05-13 RU RU98102410/14A patent/RU2194496C2/ru not_active IP Right Cessation
- 1997-05-13 WO PCT/JP1997/001595 patent/WO1997042952A1/ja active IP Right Grant
- 1997-05-13 US US08/981,475 patent/US6139866A/en not_active Expired - Lifetime
- 1997-05-13 CA CA002226834A patent/CA2226834A1/en not_active Abandoned
- 1997-05-13 AU AU26525/97A patent/AU734081B2/en not_active Ceased
- 1997-05-13 DK DK97918413T patent/DK0842662T3/da active
- 1997-05-13 ES ES97918413T patent/ES2176730T3/es not_active Expired - Lifetime
- 1997-05-13 BR BR9706591-9A patent/BR9706591A/pt not_active Application Discontinuation
- 1997-05-13 DE DE69713989T patent/DE69713989T2/de not_active Expired - Lifetime
- 1997-05-13 EP EP97918413A patent/EP0842662B1/de not_active Expired - Lifetime
- 1997-05-13 KR KR10-1998-0700087A patent/KR100486705B1/ko not_active IP Right Cessation
- 1997-05-13 CN CN97190526A patent/CN1119997C/zh not_active Expired - Fee Related
-
1998
- 1998-01-12 NO NO19980126A patent/NO316868B1/no not_active Application Discontinuation
- 1998-09-17 HK HK98110672A patent/HK1009746A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0842662B1 (de) | 2002-07-17 |
DK0842662T3 (da) | 2002-10-07 |
AU734081B2 (en) | 2001-05-31 |
HK1009746A1 (en) | 1999-09-03 |
US6139866A (en) | 2000-10-31 |
NO980126D0 (no) | 1998-01-12 |
BR9706591A (pt) | 1999-12-28 |
KR100486705B1 (ko) | 2005-06-16 |
TW411277B (en) | 2000-11-11 |
EP0842662A4 (de) | 1999-02-24 |
CN1193275A (zh) | 1998-09-16 |
PL324492A1 (en) | 1998-05-25 |
PL188205B1 (pl) | 2004-12-31 |
ID16894A (id) | 1997-11-20 |
EP0842662A1 (de) | 1998-05-20 |
NO316868B1 (no) | 2004-06-07 |
DE69713989T2 (de) | 2003-02-27 |
PT842662E (pt) | 2002-10-31 |
CA2226834A1 (en) | 1997-11-20 |
NO980126L (no) | 1998-03-10 |
ES2176730T3 (es) | 2002-12-01 |
KR19990028787A (ko) | 1999-04-15 |
CN1119997C (zh) | 2003-09-03 |
ZA974073B (en) | 1997-12-09 |
RU2194496C2 (ru) | 2002-12-20 |
AU2652597A (en) | 1997-12-05 |
ATE220545T1 (de) | 2002-08-15 |
AR007090A1 (es) | 1999-10-13 |
WO1997042952A1 (fr) | 1997-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69713989D1 (de) | Fentanyl enthaltendes transdermal-pflaster | |
ITMI981889A0 (it) | Cerotto transdermico | |
DE69824566D1 (de) | Calciumrezeptor-inhibitoren | |
NO980240L (no) | Paroxetin-kontrollert frigjörings-blandinger | |
DK0799819T3 (da) | 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning | |
DE69530614D1 (de) | Iontophorese pflaster | |
ATE272062T1 (de) | Spirocyclisch metalloprotease inhibitoren | |
BR9600216A (pt) | Formulação de emplastro de xanomelina transdérmica | |
ID21763A (id) | Perawatan untuk peradangan persendian | |
ID18417A (id) | Inhibitor ditentat metaloprotease | |
BR9607722A (pt) | Formulação transdérmica | |
NO983090D0 (no) | Terapeutiske forbindelser | |
DE69824436D1 (de) | Zahnärtzliche abtragungsvorrichtung | |
DE69821096D1 (de) | Pflaster-zubereitungen zur transdermalen absorption | |
NO993855D0 (no) | Töyelig transdermalt terapeutisk system | |
ATA102996A (de) | Steinpflaster | |
DK0963312T3 (da) | Forankringsindretning | |
PT1021384E (pt) | Regeneracao de materiais de gesso | |
KR970049739U (ko) | 철근 받침대 | |
KR970001996U (ko) | 철근받침대 | |
FI962848A0 (fi) | Vattenavstoetande mekaniskt haollfast gipsskiva | |
FI961195A0 (fi) | Briketterings- och krossningsmaskin foer plaster | |
FI960435A0 (fi) | Lääkkeiden transdermaalisen antotapaan tarkoitettuLääkkeiden transdermaalisen antotapaan tarkoitettu koostumus koostumus | |
DE69736088D1 (de) | Dentalmaterial | |
NO20016387D0 (no) | Plaster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN |